SSY Group Wins China Approval for Sodium Glycerophosphate Injection
I'm PortAI, I can summarize articles.
SSY Group Ltd. has received approval from China's National Medical Products Administration for its Sodium Glycerophosphate Injection (10ml: 2.16g). This is the third such approval for the group in China. The injection is used as a phosphorus supplement for adult parenteral nutrition and for patients with phosphorus deficiency.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments